scholarly journals A CASE OF ADULT-ONSET, STEROID-RESISTANT ASTHMA DIAGNOSED AS BRONCHOCENTRIC GRANULOMATOSIS RESPONSIVE TO MEPOLIZUMAB

CHEST Journal ◽  
2019 ◽  
Vol 156 (4) ◽  
pp. A1406
Author(s):  
Bhavik Gupta ◽  
Brian Stephenson ◽  
Ajeet Vinayak
2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
Huanqin Han ◽  
Shujun Wang ◽  
Yanting Liang ◽  
Jieping Lin ◽  
Lei Shi ◽  
...  

Aims/Introduction. Steroid resistance and frequent relapse are problems in the treatment of minimal change disease (MCD). However, epidemiological factors that influence steroid-resistant and relapse of MCD are rarely reported. This study evaluated potential factors that influence the onset and relapse of MCD and the epidemiological features of southern Chinese patients with adult-onset MCD. Patients and Methods. Patients with adult-onset MCD were included from the Affiliated Hospital of Guangdong Medical University, which is located in the southernmost part of China’s mainland, between 2015 and 2016. Potential influencing factors were investigated. Results. Eighty-seven patients with incipient MCD were enrolled, and 85 of these patients were followed up; 71.8% (61/85) were steroid-sensitive and 28.2% (24/85) were steroid-resistant. In terms of seasonal distribution, the highest rate of incipient cases was in spring (39.1%, 34/87), which also showed a high rate of relapse cases (29.7%, 22/74). Among patients who were followed up for more than half a year and whose proteinuria completely resolved (69.4%, 59/85), 52.5% (31/59) were without relapse and 47.5% (28/59) were with relapse. Patients without relapse were older than those with relapse (P<0.05). Before disease onset, 20.7% (18/87) of patients with incipient MCD were diagnosed with infection, including 94.5% (17/18) with respiratory tract infection. Fourteen patients in complete remission posttreatment developed an infection before relapse, including 85.7% (12/14) with respiratory tract infection. Conclusion. Steroid resistance and frequent relapse are current challenges for the treatment of adult-onset MCD in southern China, and respiratory tract infection may be a risk factor for onset and relapse. Additionally, younger patients with MCD tend to have more frequent relapse.


2010 ◽  
Vol 6 (2) ◽  
pp. 344-354 ◽  
Author(s):  
Sheila Santín ◽  
Bárbara Tazón-Vega ◽  
Irene Silva ◽  
María Ángeles Cobo ◽  
Isabel Giménez ◽  
...  

PeerJ ◽  
2018 ◽  
Vol 6 ◽  
pp. e5400 ◽  
Author(s):  
Bing Zhao ◽  
Hui Han ◽  
Junhui Zhen ◽  
Xiaowei Yang ◽  
Jin Shang ◽  
...  

Background Minimal change disease (MCD) is a form of idiopathic nephrotic syndrome. Compared to children, adult-onset MCD patients are reported to have delayed responses to glucocorticoid treatment. Several studies of children have suggested detecting urinary CD80 levels to diagnose MCD. There are no effective diagnostic methods to distinguish steroid-sensitive MCD from steroid-resistant MCD unless treatments are used. Methods In a total of 55 patients with biopsy-proven MCD and 26 patients with biopsy-proven idiopathic membranous nephropathy, CD80 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) levels in serum, urine and renal tissue were analyzed. Results Steroid-sensitive MCD patients in remission had lower urinary CD80 levels and higher CTLA-4 levels than patients in relapse (156.65 ± 24.62 vs 1066.40 ± 176.76 ng/g creatinine; p < 0.0001), (728.73 ± 89.93 vs 151.70 ± 27.01 ng/g creatinine; p < 0.0001). For MCD patients in relapse, mean urinary CD80 level was higher, and CTLA-4 level was lower for those who were steroid-sensitive than those who were steroid-resistant (1066.40 ± 176.76 vs. 203.78 ± 30.65 ng/g creatinine; p < 0.0001), but the mean urinary CTLA-4 level was lower (151.70 ± 27.01 vs. 457.83 ± 99.45 ng/g creatinine; p < 0.0001). CD80 expression in glomeruli was a sensitive marker to diagnose MCD. The absent or minimal expression of CTLA-4 in glomeruli could distinguish steroid-sensitive MCD from steroid-resistant MCD. Conclusions Glucocorticoid treatment may result in complete remission for only MCD patients with strongly positive CD80 expression and negative CTLA-4 expression in glomeruli, or higher urinary CD80 level and lower CTLA-4 level.


2013 ◽  
Vol 80 (08) ◽  
pp. 121-129 ◽  
Author(s):  
Junhua Zhou ◽  
Yimiao Zhang ◽  
Gang Liu ◽  
Jun Li ◽  
Rong Xu ◽  
...  

Ob Gyn News ◽  
2005 ◽  
Vol 40 (8) ◽  
pp. 46
Author(s):  
KATE JOHNSON
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document